Newbridge Financial Services Group’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1
| Closed | -$28 | – | 1135 |
|
2023
Q3 | $28 | Hold |
1
| – | – | ﹤0.01% | 1268 |
|
2023
Q2 | $36 | Hold |
1
| – | – | ﹤0.01% | 1329 |
|
2023
Q1 | $32 | Hold |
1
| – | – | ﹤0.01% | 1389 |
|
2022
Q4 | $35 | Hold |
1
| – | – | ﹤0.01% | 1421 |
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1372 |
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1350 |
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1428 |
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1399 |
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 1216 |
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 1324 |
|
2021
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1226 |
|